Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-024322
Filing Date
2025-02-20
Accepted
2025-02-20 17:24:36
Documents
1
Period of Report
2025-02-18

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 13027
  Complete submission text file 0000950170-25-024322.txt   14559
Mailing Address C/O MATINAS BIOPHARMA HOLDINGS, INC. 1545 ROUTE 206 SOUTH, SUITE 302 BEDMINSTER NJ 07921
Business Address
Kling Douglas F (Reporting) CIK: 0001699022 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41562 | Film No.: 25647391

Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Issuer) CIK: 0001936258 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)